There’s a Pill That Helps People Quit Smoking. Why Isn’t It Sold in the U.S.?
Lisa Fucito, PhD, associate professor of psychiatry, spoke to Slate Magazine about a new review on pharmacological and e-cigarette interventions for smoking cessation and the fact that one of the effective interventions, cytisine, is not available in the United States.Source: Slate
$20M Federal Grant Renewed for Yale Tobacco Center of Regulatory Science
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have renewed a $20 million grant for the Yale Tobacco Center of Regulatory Science (TCORS). The Yale center is led by co-directors Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry; and Stephanie O’Malley, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry.
A new Yale research study will examine public health impacts of cancer-causing chemical in L.I. drinking water
Yale University scientists are preparing to launch a study on Long Island to determine the health effects of the chemical 1,4 dioxane, a contaminant likely to cause cancer in people, according to the U.S. Environmental Protection Agency. The Yale Superfund Research Center is looking for volunteers who live on Long Island, where the chemical is being detected in private wells and public water supply systems at higher levels than most of the rest of the country, to participate in the study.Source: Riverhead Local
Grant Will Help Yale Team Develop Diagnostic Tool to Evaluate Tumors
The Yale Center for Clinical Investigation (YCCI) has awarded a research pilot award to an interdisciplinary team of Yale researchers for a project titled, “Utilizing Machine Learning to Model the Volumetric Growth of Vestibular Schwannomas.”
Sticky Nanoparticles Fight Skin Cancer
Using bioadhesive nanoparticles from the laboratory of Dr. W. Mark Saltzman, Dr. Michael Girardi and his team collaborated with Dr. Saltzman and loaded them with a one-two punch of chemotherapy plus immunotherapy to study its impact in skin cancer. The results may have significant impact for how skin cancer tumors are treated.
Colorectal Cancer and Women
Colon cancer has been undergoing a similar subdivision. Researchers have known for years that colorectal cancer is the third most common cancer diagnosis in the United States and the second leading cause of cancer-related deaths. The National Cancer Institute estimates 149,500 new cases in 2021 and 53,000 deaths.
Scientists Unravel Mystery of Sex Disparities in COVID-19 Outcomes
"Age and sex are where immunological changes intersect,” says Akiko Iwasaki, PhD. Over the past year, Iwasaki and her colleagues from around the globe have compiled a rich literature of research that reveals in detail these and other factors that make the virus more lethal for men.Source: YaleNews
Understanding Immune System Blunders in Response to the Coronavirus
Genetics, gender, and even botched timing on the part of the immune response all appear important in the development of COVID-19. Akiko Iwasaki, PhD, is leading research to help us better predict who is likely to sail through a bout with COVID-19 and who may need targeted lifesaving care.
Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
Akiko Iwasaki and Gregg Gonsalves named among “50 experts to trust in a pandemic”
Yale Professor of Immunology Akiko Iwasaki and Assistant Professor of Epidemiology Gregg Gonsalves ’11 GRD ’17 were named on the “50 experts to trust in a pandemic” list. The list, curated by editors of the health and wellness publication “Elemental,” presents 50 professionals that people should follow on social media for evidence-based guidance during the pandemic.Source: Yale Daily News